Clinflash
易迪希
Clinflash is a portfolio company of Qiming Venture Partners operating in the biomedical technology space . The company, also referred to as 易迪希 (Yidixi), has developed Clinflash EDC, a clinical trial electronic data capture system that recently added an AI-powered intelligent recognition and import feature designed to improve the efficiency and accuracy of LNR data entry . Qiming Venture Partners has also invested in other biomedical innovation companies alongside Clinflash, including Aisha Medical (艾莎医学) and Yiyong Technology (壹永科技) . elsewhere's corpus does not contain additional detail on Clinflash's founding, scale, or full product scope.
AI-generated — may contain errors, please verify.
Coverage
Qiming Headlines: Intelligence Ignites the Future — Qiming Venture Partners' 17th RMB Fund Annual Meeting and Investor Summit Successfully Held in Shanghai
Qiming Venture Partners Maintains Investment Discipline, Proactively Captures Market Opportunities as Deal Flow Continues
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 26, 2025
Join us in spotlighting milestone moments for companies in Qiming Venture Partners' portfolio.
Qiming Venture Partners' Kan Chen: AI's Transformation of Biomedicine Is Already Evident
In the AI era, drug discovery is taking on the characteristics of data-driven, high-throughput, automated, and intelligent processes, potentially improving success rates and lowering costs. In the near term, the necessity of experimental validation will remain unchanged; over the long run, the foundational theories of biology will stay stable. This balance between transformation and continuity is reshaping the entire landscape of pharmaceutical R&D.
